🔗 Share this article

The top legal official in Texas Ken Paxton is suing the manufacturers of Tylenol, alleging the companies hid alleged dangers that the drug posed to children's cognitive development.

The lawsuit comes a month after President Donald Trump promoted an unproven link between taking acetaminophen - referred to as paracetamol - throughout gestation and autism in offspring.

Paxton is filing suit against the pharmaceutical giant, which formerly manufactured the drug, the only pain reliever suggested for women during pregnancy, and the current manufacturer, which currently produces it.

In a declaration, he stated they "misled consumers by profiting off of pain and promoting medication regardless of the risks."

The company asserts there is insufficient reliable data connecting acetaminophen to autism.

"These companies misled for generations, intentionally threatening numerous people to line their pockets," Paxton, a Republican, declared.

Kenvue commented that it was "deeply concerned by the spread of false claims on the safety of paracetamol and the potential impact that could have on the well-being of US mothers and children."

On its online platform, Kenvue also mentioned it had "regularly reviewed the pertinent research and there is lacking reliable evidence that demonstrates a verified association between taking acetaminophen and autism."

Associations representing physicians and medical practitioners share this view.

The American College of Obstetricians and Gynecologists has declared paracetamol - the key substance in acetaminophen - is a restricted selection for expectant mothers to treat discomfort and elevated temperature, which can pose serious health risks if not addressed.

"In more than two decades of studies on the utilization of acetaminophen in gestation, zero credible investigations has definitively established that the usage of paracetamol in any stage of pregnancy causes brain development issues in offspring," the group stated.

This legal action references recent announcements from the former administration in asserting the medication is allegedly unsafe.

Recently, the former president caused concern from health experts when he told expectant mothers to "struggle intensely" not to use acetaminophen when unwell.

The US Food and Drug Administration then published an announcement that medical professionals should consider limiting the use of Tylenol, while also stating that "a direct connection" between the medication and autism spectrum disorder in young ones has not been established.

The Health Department head Robert F Kennedy Jr, who supervises the FDA, had promised in spring to undertake "extensive scientific investigation" that would identify the source of autism spectrum disorder in a short period.

But experts cautioned that discovering a sole reason of autism spectrum disorder - considered by experts to be the result of a intricate combination of inherited and surrounding conditions - would prove challenging.

Autism spectrum disorder is a category of enduring cognitive variation and condition that affects how persons perceive and interact with the environment, and is recognized using doctors' observations.

In his lawsuit, the attorney general - aligned with the former president who is campaigning for federal office - claims the manufacturer and Johnson & Johnson "willfully ignored and sought to suppress the evidence" around paracetamol and autism spectrum disorder.

This legal action seeks to make the firms "destroy any promotional materials" that claims Tylenol is secure for pregnant women.

This legal action echoes the concerns of a assembly of parents of children with autism and attention deficit hyperactivity disorder who sued the manufacturers of Tylenol in two years ago.

A federal judge dismissed the case, declaring research from the parents' expert witnesses was not conclusive.